An AI model using mammogram images predicts 5-year breast cancer risk more accurately than traditional breast density assessment.
Key Details
- 1The study is presented at the RSNA annual meeting in Chicago.
- 2Clairity Breast, the first FDA-authorized image-only AI breast cancer risk model, was trained on over 421,000 mammograms.
- 3AI model performance was evaluated on more than 245,000 screening mammograms from the US and Europe.
- 4Women in the AI high-risk group had a >4x higher incidence of cancer (5.9%) than average-risk (1.3%), while density-based separation was modest (3.2% vs. 2.7%).
- 5Findings support integrating image-only AI risk scores with traditional risk factors for more personalized screening strategies.
Why It Matters
This research advances precision screening in breast imaging, offering radiologists a more nuanced, data-driven tool for risk stratification. Early identification of high-risk patients via AI could lead to tailored screening protocols and improved outcomes.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.